BioCentury
ARTICLE | Company News

Vical, J&J deal

June 24, 2002 7:00 AM UTC

VICL and JNJ's Centocor Inc. subsidiary (Malvern, Penn.) expanded a 1998 deal to use VICL's naked DNA technology to develop DNA cancer vaccines (see BioCentury, Feb. 17, 1998). VICL will receive an u...